batrachotoxinin A 20-alpha-benzoate

AIM To investigate the efficacy, safety and tolerability of intradermal and/or submucosal administration of botulinum toxin type… (More)

Here we provide behavioural evidence for an axonal transport and the central origin of the antinociceptive effect of botulinum… (More)

Botulinum type-A (BTX-A) neurotoxin exerts a paralytic effect on muscles and is used increasingly to treat a variety of muscle… (More)

PURPOSE Intraprostatic injection of BTX-A has demonstrated clinical improvement in men with bladder outlet obstruction. We… (More)

PURPOSE We evaluated a putative inhibitory effect of intravesical botulinum toxin A (BTX-A) on afferent pathways in conditions of… (More)

AIM To test antinociceptive properties of botulinum toxin type A (BTX-A) in rats with carrageenan- and capsaicin-induced pain and… (More)

PURPOSE There is evidence that botulinum toxin A (BTX-A) might have analgesic properties. However, the mechanisms by which BTX-A… (More)

OBJECTIVE To evaluate the safety and efficacy of botulinum toxin type A (BTX-A) (BOTOX) over 16 months in the treatment of… (More)

This preclinical study compared the muscle weakening efficacy, duration, and safety margin of the recently approved botulinum… (More)

Mice of two inbred strains, DBA and C3H, were infused i.v. with saline, or 2, 4 or 6 mg/kg/hr of nicotine for 10 days. Two hours… (More)